Public Profile

Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc., a leading biopharmaceutical company headquartered in the United States, is dedicated to developing innovative treatments for addiction and related disorders. Founded in 2014, Opiant has made significant strides in the industry, particularly with its flagship product, Narcan® (naloxone), which is pivotal in reversing opioid overdoses. With a focus on addressing the urgent needs of patients and healthcare providers, Opiant's unique approach combines advanced science with a commitment to public health. The company operates primarily in the US but is also expanding its reach into international markets. Recognised for its contributions to combating the opioid crisis, Opiant continues to solidify its position as a key player in the biopharmaceutical sector, striving to improve lives through effective and accessible treatment solutions.

DitchCarbon Score

How does Opiant Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Opiant Pharmaceuticals, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Opiant Pharmaceuticals, Inc.'s reported carbon emissions

Opiant Pharmaceuticals, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of data may indicate that the company is in the early stages of developing a comprehensive sustainability strategy. As the pharmaceutical industry increasingly prioritises environmental responsibility, Opiant may consider establishing measurable targets and initiatives to align with industry standards and contribute to global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Opiant Pharmaceuticals, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Opiant Pharmaceuticals, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Opiant Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

DMK Pharmaceuticals Corporation

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Padagis US LLC

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Emergent BioSolutions

US
Research and development services (73)
Updated about 1 hour ago

Phastar

GB
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Harm Reduction Therapeutics (HRT), Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers